Dupixent
Active substance: dupilumab
dupilumab
Centralised EU authorisationActive
Marketing holder: Sanofi Winthrop Industrie
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Composition
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 2 |
|
| US 4 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-aff8-75f6-affe-de6830d53947,01a120c5-cefa-7dbb-baf4-712d195351e8;count=2 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-88e1-7d70-a4b3-3b458be70373,01a1208f-fce1-7f33-854b-65e76391ec82,01a1209b-51ff-71fc-9bf7-8e3aa27d46af,01a1209b-5258-7eca-88d1-9eed75c109ab;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/004390
- Registration status
- Active
- ATC code
- D11AH05
Sources
- product · EMA · EMEA/H/C/004390 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/004390 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/004390 · Verified 2026-10-09